Pancreatic Cancer Research

ResearcherNational Center for Oncological HadrontherapyActive in the last 2 years

Angelica Facoetti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8215-9258; OpenAlex author ID A5029708612. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 8

  1. Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancer. Co-author DOI 10.1038/s41698-025-00800-4↗
  2. Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936). Co-author DOI 10.1177/03008916241291341↗
  3. Multimodal evaluation of 19F-BPA internalization in pancreatic cancer cells for boron capture and proton therapy potential applications. Co-author DOI 10.1016/j.ejmp.2021.12.011↗
  4. Factors released by low and high-LET irradiated fibroblasts modulate migration and invasiveness of pancreatic cancer cells. Last author DOI 10.3389/fonc.2022.1003494↗
  5. Hadron Therapy, Magnetic Nanoparticles and Hyperthermia: A Promising Combined Tool for Pancreatic Cancer Treatment. Co-author DOI 10.3390/nano10101919↗
  6. Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, mul… Co-author DOI 10.1186/s12885-019-6108-0↗
  7. Evidence of 68Ga-DOTA-NT-20.3 Uptake in Pancreatic Adenocarcinoma AsPC-1 Cell Line - in vitro Study. Co-author DOI 10.2174/1389201019666180829152314↗
  8. Morphological Analysis of Amoeboid-Mesenchymal Transition Plasticity After Low and High LET Radiation on Migrating and Invading Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.12763↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mario Ciocca · 5 shared papers, 2018–2025 · strength 0.65
  2. Amelia Barcellini · 3 shared papers, 2019–2024 · strength 0.43
  3. Ester M. Orlandi · 2 shared papers, 2022–2024 · strength 0.35
  4. Francesca Valvo · 3 shared papers, 2018–2024 · strength 0.34
  5. Viviana Vitolo · 2 shared papers, 2019–2024 · strength 0.26
  6. Silvia Molinelli · 2 shared papers, 2019–2024 · strength 0.26
  7. Todd Anthony Aguilera · 1 shared paper, 2025 · strength 0.22
  8. Katy L. Swancutt · 1 shared paper, 2025 · strength 0.22
  9. Anthony J. Davis · 1 shared paper, 2025 · strength 0.22
  10. Brock J. Sishc · 1 shared paper, 2025 · strength 0.22
  11. Giovanni Butturini · 1 shared paper, 2024 · strength 0.18
  12. Alexandra Charalampopoulou · 1 shared paper, 2022 · strength 0.16
  13. Roberto Orecchia · 2 shared papers, 2018–2019 · strength 0.16
  14. Silvia Capuani · 1 shared paper, 2022 · strength 0.11
  15. Andrea Ciardiello · 1 shared paper, 2022 · strength 0.11
  16. Marina Hodolič · 1 shared paper, 2018 · strength 0.09
  17. Manuela Marenco · 1 shared paper, 2018 · strength 0.09
  18. Lorenzo Cobianchi · 1 shared paper, 2019 · strength 0.08
  19. A. Lascialfari · 1 shared paper, 2020 · strength 0.08
  20. Francesca Brero · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.